SMIC Reports Q1 Earnings: Shareholder Profit Hits $197 Million, Up 14.2% Sequentially and 5% Year-on-Year

Stock News05-15 09:08

Key Announcements: Hengrui Medicine (01276): RSS0393 Emulsion Approved for Clinical Trials Longqi Technology (09611) Plans to Invest $41 Million to Subscribe to an Overseas Cloud Computing Power Investment Fund China Antibody-B (03681) to Present Preclinical Research on Anti-CGC Antibody (hC2) at the 2026 SID Annual Meeting Dongpeng Beverage (09980): Chengdu Base Signs "State-owned Construction Land Use Right Transfer Contract" with Chengdu Wenjiang District Planning and Natural Resources Bureau Hengrui Medicine (01276) Subsidiary Receives "Drug Clinical Trial Approval Notice" for SHR-3079 Injection from the National Medical Products Administration

Operational Performance: Huahong Semiconductor (01347) Releases Q1 Results: Shareholder Attributable Profit of $20.9 Million, Up 458.1% Year-on-Year China Gold International (02099) Releases Q1 Results: Quarterly Net Profit Surpasses $200 Million for the First Time, Setting a New Record SMIC (00981) Announces Q1 Results: Company Owner's Attributable Profit of Approximately $197 Million, Up 14.2% Sequentially and 5% Year-on-Year Ali Health (00241) Annual Adjusted Net Profit Reaches RMB 23.262 Billion, Up 19.3% Year-on-Year

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment